Blog
My Take: 4 Strong Growth Stocks to Buy This Week
Rising inflation and the threat of higher interest rates have crushed many of the market's favorite growth stocks over the past few months. That sell-off wasn't surprising, but plenty of babies were
3 Must-Know Tax Rules to Protect Your Money From Capital Gains
One thing that separates regular income and investment income is how the IRS views them when it comes to taxes. Knowing the differences between the two can not only save you from a surprise tax
Here's What to Like About Johnson & Johnson's Q4 Update
Healthcare giant Johnson & Johnson (NYSE: JNJ) reported its fourth-quarter results on Jan. 25, 2022. In this Motley Fool Live video, recorded on Jan. 26, Fool contributors Keith Speights and Brian
Merck Coughs Up a Failure With Its "Pipeline in a Product"
Merck (NYSE: MRK) has high hopes for gefapixant, an experimental drug that it's referred to as a "pipeline in a product." However, the U.S. Food and Drug Administration (FDA) recently poured some
Is It Too Late to Buy Microsoft?
With the recent sell-off in technology stocks, some investors may be looking at the large-cap tech giants for their portfolio. However, these tech giants have been the big outperformers over the
Why Jack Dorsey's Opinion on Bitcoin Scares Me
Block (NYSE: SQ) Chief Executive Officer Jack Dorsey is a Bitcoin (CRYPTO: BTC) extremist. I know extremist is kind of a charged word. I don't necessarily mean it in a negative way. Many people are
RH Is a Wonderful Business at a Great Price
Warren Buffett has spoken of the advantages of buying a wonderful company at a fair price, instead of a fair company at a wonderful price. And the recent market sell-off has gone one step further
How Concerning Is Pfizer and Opko's Latest FDA Rejection?
The U.S. Food and Drug Administration (FDA) recently refused to approve Pfizer's (NYSE: PFE) and Opko Health's (NASDAQ: OPK) growth hormone therapy, somatrogon. In this Motley Fool Live video
Better Buy: BlackBerry vs. Apple
Back in 2010, BlackBerry (NYSE: BB) accounted for 43% of the smartphone platform market, according to Comscore. But over the following decade, it lost the entire market to Apple's (NASDAQ: AAPL)
Here's My Top Cryptocurrency to Buy in February
It has been a difficult past few months for cryptocurrencies, as most of the major names have plunged from November highs. The crypto market as a whole has gone from about $3 trillion to its current
Are Beaten-Down Dividend Stocks a Bargain or a Trap?
The stock market has been under pressure lately, and many of investors' favorite dividend stocks have fallen significantly from the highs, pushing yields higher in the process. In this Fool Live
Can Intel Catch Up to Taiwan Semiconductor by 2025?
In this segment of "Semiconductor Revolution" on Motley Fool Live, recorded on Jan. 20, Fool contributor Will Healy discusses Intel's (NASDAQ: INTC) ambitious plans to compete with TSMC (NYSE: TSM)
Should Investors Expect Aurora Cannabis to Post a Profit in Q2?
Cannabis company Aurora Cannabis (NASDAQ: ACB) reports its fiscal second-quarter earnings this month. The business has been working on improving its bottom line and while there has been progress in
Shifting Toward Bonds as Retirement Nears? 3 Mistakes to Avoid
There's a reason workers are often advised to load up on stocks in the course of saving for retirement. If you want to grow your IRA or 401(k) through the years, stocks are a good bet because
5 Charts That Show Roblox's Metaverse Success Is Very Real
There is a lot of talk these days about the metaverse -- a term that has been defined in several ways. In general, though, it references a persistent digital space where users can be immersed in a
Brinker International (EAT) Q2 2022 Earnings Call Transcript
Image source: The Motley Fool.
Brinker International (NYSE: EAT)Q2 2022 Earnings CallFeb 02, 2022, 10:00 a.m. ET
Operator
Source Fool.com
2 Stocks to Grab Now That the S&P 500 Is In Correction Territory
When a stock or index falls 10% from its all-time high, it is said to be in correction territory. While this isn't as scary-sounding as a bear market -- denoted by a 20% fall -- it should give
Is SoFi's Bank Charter a Risk or Opportunity?
It was recently reported that fintech disruptor SoFi Technologies (NASDAQ: SOFI) has officially been approved to become a bank. In this Fool Live video clip, recorded on Jan. 20, Fool.com
Shiba Inu Is Down 75%. Should You Buy It Now?
Whether you're an avid investor or curious observer, by now you're probably familiar with the popular cryptocurrency Shiba Inu (CRYPTO: SHIB). It stirred up a speculative frenzy in October 2021 --
1 Top Metaverse Stock to Buy Now and Hold
The metaverse is still an evolving and nebulous technology, and we are probably several years away from seeing it in action. Even so, the basic concept is straightforward: The metaverse will be a
A REIT for Your Sweet: This Stock Will Keep on Giving for Years
Stumped for Valentine's Day this year? Gifting your significant other like royalty with shares of Essex Property Trust (NYSE: ESS) can be a good investment in your personal and financial futures.
Could Bitcoin Hit $10 Trillion by 2030?
Bitcoin (CRYPTO: BTC), the world's most valuable cryptocurrency, was worth $729 billion as of Jan. 31, but it hasn't been immune to the whims of the broader market. Digital assets have taken a hit
2 Cash-Burning Growth Stocks to Stay Far Away From
Growth stocks can be great long-term investments to hang on to. But they can be problematic for investors if the companies are burning through tons of cash, as that can result in them taking on debt
How Big Are Gilead's Latest COVID Wins?
The U.S. Food and Drug Administration (FDA) recently expanded the label for Gilead Sciences' (NASDAQ: GILD) COVID-19 therapy Veklury (remdesivir) to be used in treating non-hospitalized adults. In
My 3 Biggest Stock Market Predictions for February
Major stock market indexes lost trillions of dollars in value last month. Uncertainty and volatility are still major concerns for investors as we move into February. It's a challenging environment


